TODAY: AACR Special Conference on Pancreatic Cancer in Boston
BOSTON – This evening, the American Association for Cancer Research (AACR) will kick off the AACR Special Conference: Pancreatic Cancer at Westin Copley Place in Boston. This conference will address the latest developments in pancreatic cancer research, spanning basic, translational, and clinical research areas.
PANCREATIC CANCER EXPERT AVAILABILITY
The conference co-chairs are available to provide expert commentary on the studies presented at the conference:
- Christine A. Iacobuzio-Donahue, MD, PhD, Memorial Sloan Kettering Cancer Center
- Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center
- Rosalie C. Sears, PhD, Oregon Health & Science University
- Jen Jen Yeh, MD, University of North Carolina, Chapel Hill
PRESENTATION OF INTEREST
The conference organizers have identified an abstract that may be of interest to the media. This study will be presented during Poster Session C, which begins at 4:40 p.m. ET on Friday, September 29.
Abstract Title: T cell responses and clinical outcomes in pancreatic and colorectal cancer patients with Minimal Residual Disease in AMPLIFY-201, a phase 1 trial of a first-in-class amphiphile lymph node targeted mutant KRAS vaccine
Presenter: Eileen M. O’Reilly, MD, Memorial Sloan Kettering Cancer Center
View the full conference program on the AACR’s website.
Registration is complimentary for credentialed members of the media. This meeting will take place as an in-person event. Lecture sessions will be made available for on-demand viewing approximately 7-10 days after the meeting has concluded.
To request media registration, please review the AACR’s media registration requirements and policies and fill out this form. Contact Cyprien Pearson-Du Toit at [email protected] with any registration questions.
For more information, contact a member of the AACR public relations team: